A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
- Submitting institution
-
The University of Sheffield
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 10
- Type
- D - Journal article
- DOI
-
10.1016/j.eururo.2015.08.035
- Title of journal
- European Urology
- Article number
- -
- First page
- 450
- Volume
- 69
- Issue
- 3
- ISSN
- 0302-2838
- Open access status
- Out of scope for open access requirements
- Month of publication
- September
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
13
- Research group(s)
-
B - Cancer
- Citation count
- 53
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
